SCHEMBL539883

SCHEMBL539883

CC(C)(C)OC(=O)c1ccc2ccncc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.44
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
ABCG2 Q9UNQ0 2/20 0.41
ABCB1 P08183 1/20 0.41
HIPK2 Q9H2X6 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
KDM4E B2RXH2 1/20 0.41
RAPGEF3 O95398 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRG2 P18507 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4353066 0.94 CYP19A1 (0.47) CYP19A1CYP11B1CYP11B2ABCG2ABCB1
SCHEMBL31274989 0.83 CYP19A1 (0.61) CYP19A1CYP11B1CYP11B2CA12CA1
SCHEMBL6200155 0.83 CYP19A1 (0.61) CYP19A1CYP11B1CYP11B2CA12CA1
SCHEMBL8390404 0.82 GABRA1 (0.50) CYP19A1CYP11B1CYP11B2CA12CA1
SCHEMBL28797135 0.81 HDAC3 (0.41) CYP19A1CYP11B1CYP11B2HIPK2NPC1
SCHEMBL4149676 0.80 HIPK2 (0.44) HIPK2NPC1RAB9AKDM4ERAPGEF3
SCHEMBL1415273 0.79 CES2 (0.55) NPC1RAB9AKDM4EGABRA1GABRG2
SCHEMBL27850053 0.79 ALDH1A1 (0.53) CYP19A1CYP11B1CYP11B2CA12CA1
SCHEMBL5744947 0.79 RAB9A (0.52) CA12CA1CA2CA9CA14
SCHEMBL1871973 0.78 HSD17B10 (0.53) CA12CA1CA2CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102378574-A Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof TRANSTECH PHARMA INC 2012-03-14 CN disclosed
EP-2413693-A1 SUBSTITUTED AZOANTHRACENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF TransTech Pharma, Inc (US) 2012-02-08 EP disclosed
WO-2010114824-A1 SUBSTITUTED AZOANTHRACENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF TRANSTECH PHARMA INC (US) 2010-10-07 WO disclosed
US-4396619-A ANTIBIOTICS ELI LILLY AND COMPANY (US) 1983-08-02 US disclosed
US-4382932-A Isoquinolinium substituted cephalosporins ELI LILLY AND COMPANY (US) 1983-05-10 US disclosed